← ANALYST RATINGS · TIPRANKS
Envista Holdings (NVST): analyst forecast and price target
Analyst consensus
Moderate Buy7 Buy8 Hold0 Sell
Ratings of 15 analysts in the last 3 months12-month forecast
Based on 15 price targets given in the last 3 months, the average target is $29.38, the highest $34.00, the lowest $23.00. The average is +28.3% from the last price of $22.90.
Analyst ratings 17
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $24.50 → $24.00−2.0% | Hold | +4.8% | Reiterated | 17.10.26on TipRanks 14:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $25.00 → $24.50−2.0% | Hold | +7.0% | Reiterated | 17.10.26on TipRanks 14:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $25.00 → $24.50−2.0% | Hold | +7.0% | Reiterated | 17.10.26on TipRanks 14:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $24.50 → $23.50−4.1% | Hold | +2.6% | Reiterated | 17.10.26on TipRanks 14:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $26.00 → $25.00−3.8% | Hold | +9.2% | Downgrade | 17.10.26on TipRanks 14:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $26.00 → $25.00−3.8% | Hold | +9.2% | Reiterated | 17.10.26on TipRanks 14:05 | — | |
| Jeff Johnson★★★★★★★★★★#1125 · hits 51% · avg +10.4% | Robert W. Baird | $34.00 → $26.00−23.5% | Hold | +13.5% | Downgrade | 15.10.26on TipRanks 05:30 | +2.7%next day −1.4% | ↗ |
| Michael Cherny★★★★★★★★★★#2074 · hits 57% · avg +5.7% | Leerink Partners | $35.00 → $32.00−8.6% | Buy | +39.7% | Reiterated | 14.10.26on TipRanks 09:00 | +1.8%next day +2.7% | ↗ |
| Jason Bednar★★★★★★★★★★#11450 · hits 46% · avg −2.5% | Piper Sandler | $28.00 → $26.00−7.1% | Hold | +13.5% | Reiterated | 09.10.26on TipRanks 07:11 | +0.6%next day −1.2% · 5 days +1.5% | ↗ |
| Allen Lutz★★★★★★★★★★#598 · hits 67% · avg +12.3% | Bank of America Securities | $34.00 | Buy | +48.5% | Reiterated | 07.10.26on TipRanks 10:00 | −0.7%next day −1.0% · 5 days 0.0% | ↗ |
| Brandon Vazquez★★★★★★★★★★#11688 · hits 42% · avg −5.1% | William Blair | — | Buy | — | Reiterated | 02.10.26on TipRanks 10:06 | +0.6%next day −1.2% · 5 days −3.1% | ↗ |
| Vik Chopra★★★★★★★★★★#6076 · hits 45% · avg +1.9% | BMO Capital | $29.00 → $26.00−10.3% | Hold | +13.5% | Reiterated | 28.09.26on TipRanks 07:25 | −0.2%next day −1.5% · 5 days −2.8% | ↗ |
| David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% | Needham | — | Hold | — | Reiterated | 24.09.26on TipRanks 06:35 | +1.1%next day −1.0% · 5 days −3.4% | ↗ |
| Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% | Morgan Stanley | $23.00 | Hold | +0.4% | Reiterated | 18.09.26on TipRanks Sep 20 20:55 | −1.6%next day −1.2% · 5 days +1.3% | ↗ |
| Jonathan Block★★★★★★★★★★#2320 · hits 50% · avg +5.3% | Stifel Nicolaus | $31.00 | Buy | +35.4% | Reiterated | 18.09.26on TipRanks 08:35 | −1.6%next day −1.2% · 5 days +1.3% | ↗ |
| Unknown Analyst | Leerink Partners | $35.00 | Buy | +52.8% | Reiterated | 18.09.26on TipRanks 08:35 | −1.6%next day −1.2% · 5 days +1.3% | ↗ |
| Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% | UBS | $30.00 → $27.00−10.0% | Hold | +17.9% | Reiterated | 18.09.26on TipRanks 07:35 | −1.6%next day −1.2% · 5 days +1.3% | ↗ |
| Lilia-Celine (Lily) Lozada★★★★★★★★★★#7724 · hits 75% · avg +5.0% | J.P. Morgan | $32.00 | Buy | +39.7% | Upgrade | 03.09.26on TipRanks 05:35 | −0.3%next day −0.7% · 5 days −6.2% | ↗ |
| Glen Santangelo★★★★★★★★★★#2956 · hits 52% · avg +4.5% | Barclays | $32.00 | Buy | +39.7% | Reiterated | 17.08.26on TipRanks Aug 18 05:25 | −1.1%next day +1.3% · 5 days +0.1% | ↗ |
| Daniel Grosslight★★★★★★★★★★#4007 · hits 47% · avg +3.6% | Citi | $32.00 | Hold | +39.7% | Reiterated | 10.08.26on TipRanks 16:30 | +1.5%next day +0.4% · 5 days −2.1% | ↗ |
| Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% | Evercore ISI | $32.00 | Buy | +39.7% | Reiterated | 06.08.26on TipRanks 08:25 | −4.2%next day +2.2% · 5 days +1.3% | ↗ |
| Steven Valiquette★★★★★★★★★★#8240 · hits 53% · avg 0.0% | Mizuho Securities | $27.00 → $29.00+7.4% | Hold | +26.6% | Reiterated | 06.08.26on TipRanks 07:25 | −4.2%next day +2.2% · 5 days +1.3% | ↗ |
| Unknown Analyst | Wells Fargo | $21.00 → $26.00+23.8% | Hold | +13.5% | Reiterated | 06.02.26on TipRanks 08:00 | +15.8%next day +0.4% · 5 days +0.8% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Envista Holdings
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 02.10.26: target $30.38 at a price of $23.16 (+31.2%); now: $29.38 at $22.90 (+28.3%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 8 | 9 | 9 | 9 | 15 | 17 |
| Hold | 6 | 6 | 7 | 9 | 18 | 17 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 04.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.36 (from $0.34 to $0.38). Last quarter: $0.41.
Sales
Next quarter’s sales estimate — $689M (from $684M to $701M). Last quarter: $730M.
Best top-analyst consensus in the sector · Healthcare
About Envista Holdings
- CEO: Paul A. Keel
- Employees: 12,000
- Building E, Brea, CA, 92821-6208, US
- www.envistaco.com
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
Data from the stock’s TipRanks forecast page, read 27 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗